Pharma

New Delhi, 1st, June 2022: Kairali Ayurvedic Products Pvt Ltd (KAPPL), a division of over hundred ten year old Authentic Ayurveda promoter Kairali  Ayurvedic Group has expanded its distribution network in east Delhi, Nashik & across Kerala.  While Manki Drug House, with 25 years of experience in promoting Ayurvedic Products will look at distribution of Kairali Products across Kerala, Bansal & Sons with 13 years...

IIFL Securities, India’s leading distribution and broking firm, has launched a unique product Advisory Anytime Anywhere (AAA) – a tablet which allows youngsters to start their own business at no fixed cost. Those who would like to start a financial advisory business, but are deterred by the entry barriers of manpower, office space, SEBI registration, research inputs and...

A single dose of Johnson & Johnson's experimental COVID-19 vaccine produced a strong immune response against the novel coronavirus in an early-to-mid stage clinical trial, according to interim results published on Friday. The vaccine, called Ad26.COV2.S, was equally well-tolerated at two different doses, the results showed. A single shot, versus a rival two-dose approach being tested by Moderna Inc and...

Hyderabad, 31st May 2022: OMRON Healthcare India, one of the leading players in the digital home blood pressure monitoring segment, today announced support towards the #THEBIGSQUEEZE movement to bolster the ongoing ‘May Measurement Month (MMM)’ global campaign in India. This movement aims to encourage people of all ages to get their blood pressure checked in the world’s largest FREE blood pressure screening campaign. The...

The Union Health Ministry has said it does not agree with the ₹ 80,000 crore figure cited by Adar Poonawalla, CEO of Serum Institute of India - the world's largest manufacturer of vaccines by volume and which is conducting trials of Covid vaccine candidates ahead of mass production - for buying and distributing the vaccine in the country. The...

Sun Pharmaceutical Industries Ltd and its senior officials, including Managing Director Dilip Shanghvi, on Thursday, settled with regulator Sebi a case pertaining to an alleged violation of listing obligation and disclosure requirements norms. According to separate settlement orders, Sun Pharmaceutical paid over Rs 56.11 lakh towards settlement charges and Shanghvi paid Rs 62.35 lakh. Besides, the firm's whole-time directors...

People eligible for a COVID-19 vaccine among the over-70 most at-risk groups who haven't yet had their jab are being urged by the National Health Service (NHS) to come forward this weekend in a renewed drive as the UK government nears its target of vaccinating the top priority groups by Monday. Over 12 million people in England have now received...

The Russian Direct Investment Fund (RDIF) and Dr Reddy's Laboratories Ltd have received renewed approval to conduct late-stage clinical trials in India of the Russian COVID-19 vaccine, the sovereign wealth fund said on Saturday. Large-scale trials of the Sputnik V vaccine in India were first announced and then knocked back by Indian regulators, who said the scale of Phase I...

Johnson & Johnson said Monday it had temporarily halted its Covid-19 vaccine trial because one of its participants had become sick. "We have temporarily paused further dosing in all our Covid-19 vaccine candidate clinical trials, including the  Phase 3 ENSEMBLE trial, due to an unexplained illness in a study participant," the company said in a statement. The pause means the online...

Health officials reviewing Gilead Science Inc's remdesivir against COVID-19 should consider all evidence, including a trial in which the medicine failed, before giving it the green light, the top WHO scientist said on Friday. US regulators appeared not to have done so when approving the drug this week, Soumya Swaminathan told a news conference. The US Food and Drug Administration on...